Selected research
Industry Research
Genome-Wide DNA Methylation Analysis Service Industry Research Report 2026
Market perspective
The global Genome-Wide DNA Methylation Analysis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Genome-Wide DNA Methylation Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genome-Wide DNA Methylation Analysis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genome-Wide DNA Methylation Analysis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genome-Wide DNA Methylation Analysis Service include Active Motif, EpiGentek, Zymo Research, CD Genomics, Azenta Life Sciences, Ardi Medikal, CeGaT, EpiGenie and Creative Biogene, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Genome-Wide DNA Methylation Analysis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genome-Wide DNA Methylation Analysis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genome-Wide DNA Methylation Analysis Service Market by Company
Active Motif
EpiGentek
Zymo Research
CD Genomics
Azenta Life Sciences
Ardi Medikal
CeGaT
EpiGenie
Creative Biogene
Hologic
CeGaT GmbH
Genome-Wide DNA Methylation Analysis Service Segment by Type
Whole Genome Bisulfite Sequencing (WGBS)
Reduced Representation Bisulfite Sequencing (RRBS)
Other
Genome-Wide DNA Methylation Analysis Service Segment by Application
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Clinical Diagnostics Labs
Others
Genome-Wide DNA Methylation Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome-Wide DNA Methylation Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome-Wide DNA Methylation Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome-Wide DNA Methylation Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genome-Wide DNA Methylation Analysis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Genome Bisulfite Sequencing (WGBS)
- Reduced Representation Bisulfite Sequencing (RRBS)
- Other
Applications
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Clinical Diagnostics Labs
- Others
Companies covered
- Active Motif
- EpiGentek
- Zymo Research
- CD Genomics
- Azenta Life Sciences
- Ardi Medikal
- CeGaT
- EpiGenie
- Creative Biogene
- Hologic
- CeGaT GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Genome-Wide DNA Methylation Analysis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Whole Genome Bisulfite Sequencing (WGBS)
- 2.2.3 Reduced Representation Bisulfite Sequencing (RRBS)
- 2.2.4 Other
- 2.3 Genome-Wide DNA Methylation Analysis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic and Research Institutions
- 2.3.3 Pharmaceutical and Biotechnology Companies
- 2.3.4 Clinical Diagnostics Labs
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Genome-Wide DNA Methylation Analysis Service Breakdown Data by Type
- 3.1 Global Genome-Wide DNA Methylation Analysis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Genome-Wide DNA Methylation Analysis Service Forecasted Market Size by Type (2027-2032)
4 Genome-Wide DNA Methylation Analysis Service Breakdown Data by Application
- 4.1 Global Genome-Wide DNA Methylation Analysis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Genome-Wide DNA Methylation Analysis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Genome-Wide DNA Methylation Analysis Service Market Perspective (2021-2032)
- 5.2 Global Genome-Wide DNA Methylation Analysis Service Growth Trends by Region
- 5.2.1 Global Genome-Wide DNA Methylation Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Genome-Wide DNA Methylation Analysis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Genome-Wide DNA Methylation Analysis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Genome-Wide DNA Methylation Analysis Service Market Dynamics
- 5.3.1 Genome-Wide DNA Methylation Analysis Service Industry Trends
- 5.3.2 Genome-Wide DNA Methylation Analysis Service Market Drivers
- 5.3.3 Genome-Wide DNA Methylation Analysis Service Market Challenges
- 5.3.4 Genome-Wide DNA Methylation Analysis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Genome-Wide DNA Methylation Analysis Service Players by Revenue
- 6.1.1 Global Top Genome-Wide DNA Methylation Analysis Service Players by Revenue (2021-2026)
- 6.1.2 Global Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Genome-Wide DNA Methylation Analysis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Genome-Wide DNA Methylation Analysis Service Head Office and Area Served
- 6.4 Global Genome-Wide DNA Methylation Analysis Service Players, Product Type & Application
- 6.5 Global Genome-Wide DNA Methylation Analysis Service Manufacturers Established Date
- 6.6 Global Genome-Wide DNA Methylation Analysis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Genome-Wide DNA Methylation Analysis Service Market Size (2021-2032)
- 7.2 North America Genome-Wide DNA Methylation Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Genome-Wide DNA Methylation Analysis Service Market Size by Country (2021-2026)
- 7.4 North America Genome-Wide DNA Methylation Analysis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Genome-Wide DNA Methylation Analysis Service Market Size (2021-2032)
- 8.2 Europe Genome-Wide DNA Methylation Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Genome-Wide DNA Methylation Analysis Service Market Size by Country (2021-2026)
- 8.4 Europe Genome-Wide DNA Methylation Analysis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Genome-Wide DNA Methylation Analysis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Genome-Wide DNA Methylation Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Genome-Wide DNA Methylation Analysis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Genome-Wide DNA Methylation Analysis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Genome-Wide DNA Methylation Analysis Service Market Size (2021-2032)
- 10.2 South America Genome-Wide DNA Methylation Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Genome-Wide DNA Methylation Analysis Service Market Size by Country (2021-2026)
- 10.4 South America Genome-Wide DNA Methylation Analysis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Genome-Wide DNA Methylation Analysis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Genome-Wide DNA Methylation Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Genome-Wide DNA Methylation Analysis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Genome-Wide DNA Methylation Analysis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Active Motif
- 12.1.1 Active Motif Company Information
- 12.1.2 Active Motif Business Overview
- 12.1.3 Active Motif Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.1.4 Active Motif Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.1.5 Active Motif Recent Developments
- 12.2 EpiGentek
- 12.2.1 EpiGentek Company Information
- 12.2.2 EpiGentek Business Overview
- 12.2.3 EpiGentek Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.2.4 EpiGentek Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.2.5 EpiGentek Recent Developments
- 12.3 Zymo Research
- 12.3.1 Zymo Research Company Information
- 12.3.2 Zymo Research Business Overview
- 12.3.3 Zymo Research Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.3.4 Zymo Research Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.3.5 Zymo Research Recent Developments
- 12.4 CD Genomics
- 12.4.1 CD Genomics Company Information
- 12.4.2 CD Genomics Business Overview
- 12.4.3 CD Genomics Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.4.4 CD Genomics Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.4.5 CD Genomics Recent Developments
- 12.5 Azenta Life Sciences
- 12.5.1 Azenta Life Sciences Company Information
- 12.5.2 Azenta Life Sciences Business Overview
- 12.5.3 Azenta Life Sciences Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.5.4 Azenta Life Sciences Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.5.5 Azenta Life Sciences Recent Developments
- 12.6 Ardi Medikal
- 12.6.1 Ardi Medikal Company Information
- 12.6.2 Ardi Medikal Business Overview
- 12.6.3 Ardi Medikal Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.6.4 Ardi Medikal Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.6.5 Ardi Medikal Recent Developments
- 12.7 CeGaT
- 12.7.1 CeGaT Company Information
- 12.7.2 CeGaT Business Overview
- 12.7.3 CeGaT Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.7.4 CeGaT Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.7.5 CeGaT Recent Developments
- 12.8 EpiGenie
- 12.8.1 EpiGenie Company Information
- 12.8.2 EpiGenie Business Overview
- 12.8.3 EpiGenie Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.8.4 EpiGenie Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.8.5 EpiGenie Recent Developments
- 12.9 Creative Biogene
- 12.9.1 Creative Biogene Company Information
- 12.9.2 Creative Biogene Business Overview
- 12.9.3 Creative Biogene Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.9.4 Creative Biogene Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.9.5 Creative Biogene Recent Developments
- 12.10 Hologic
- 12.10.1 Hologic Company Information
- 12.10.2 Hologic Business Overview
- 12.10.3 Hologic Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.10.4 Hologic Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.10.5 Hologic Recent Developments
- 12.11 CeGaT GmbH
- 12.11.1 CeGaT GmbH Company Information
- 12.11.2 CeGaT GmbH Business Overview
- 12.11.3 CeGaT GmbH Revenue in Genome-Wide DNA Methylation Analysis Service Business (2021-2026)
- 12.11.4 CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Product Portfolio
- 12.11.5 CeGaT GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst